Can You Get Mpox More Than Once?

Yes, it is possible to get mpox more than once, though reinfections are rare and depend on immune response and virus exposure.

Understanding Mpox Immunity and Reinfection Risks

Mpox, formerly known as monkeypox, is a viral disease caused by the mpox virus, part of the Orthopoxvirus genus. After an initial infection, the body typically develops immunity through antibodies and memory immune cells. However, this immunity may not be lifelong or absolute. The question “Can You Get Mpox More Than Once?” hinges largely on how durable and effective this immune response is.

When someone recovers from mpox, their immune system has learned to recognize the virus. This immune memory usually protects against future infections. But like many viral diseases, immunity can wane over time or might not be fully protective against different strains or variants of the virus. This means reinfection is possible under certain conditions.

Studies on mpox immunity are still evolving. Historical data from related viruses like smallpox suggest that immunity can last for years but may decline decades later. For mpox specifically, documented cases of reinfection are rare but have been reported in recent outbreaks.

The Immune Response to Mpox Virus

The immune system combats mpox by producing neutralizing antibodies and activating T-cells that target infected cells. After recovery:

Antibodies bind to the virus, preventing it from entering new cells.
Memory B-cells remember how to produce these antibodies quickly if re-exposed.
T-cells destroy infected cells to stop viral replication.

This multi-layered defense usually prevents a second infection or reduces its severity if reinfection occurs. However, factors such as individual health status, viral load during exposure, and genetic differences influence this protection level.

Factors Influencing Mpox Reinfection

Several variables affect whether someone can get mpox more than once:

Immune System Strength: People with weakened immunity (due to HIV/AIDS, immunosuppressive drugs, or other conditions) may not mount a strong defense.
Virus Variants: Different clades or mutations of the mpox virus might partially evade existing antibodies.
Time Since First Infection: Immunity may fade over months or years, increasing susceptibility.
Exposure Level: High-dose exposure to the virus could overwhelm partial immunity.

Because these factors vary widely across populations and individuals, predicting reinfection risk precisely remains challenging.

Documented Cases and Research on Mpox Reinfection

Scientific literature on confirmed mpox reinfections is limited but growing. During recent outbreaks in non-endemic countries since 2022, a few cases have surfaced where individuals tested positive for mpox twice with an interval suggesting true reinfection rather than persistent infection.

One study analyzed patients who recovered from mpox but later developed symptoms again with confirmed viral presence by PCR testing. Genetic sequencing of virus samples showed slight differences between first and second infections, supporting reinfection rather than relapse.

Another investigation found that some patients had declining antibody levels months after recovery, implying waning immunity could leave them vulnerable again.

While these findings indicate that “Can You Get Mpox More Than Once?” has an affirmative answer in some cases, they also highlight that reinfections remain uncommon compared to initial infections.

Comparing Mpox Immunity With Other Orthopoxviruses

Orthopoxviruses include smallpox (variola), vaccinia (used in vaccines), cowpox, and mpox viruses. The smallpox vaccine historically provided cross-protection against mpox due to close genetic relationships among these viruses.

Orthopoxvirus	Immunity Duration After Infection/Vaccination	Reinfection Likelihood
Smallpox (Variola)	10–20 years (vaccination), lifelong partial immunity post-infection	Very rare due to strong immunity
Mpox Virus	Months to years; exact duration unclear	Possible but rare; depends on individual factors
Cowpox Virus	Variable; often short-lived in humans	Possible due to weaker immunity

This comparison underscores that while orthopoxvirus infections generally induce protective immunity lasting months or years, exceptions exist depending on host and viral dynamics.

The Role of Vaccination in Reducing Reinfections

Vaccines based on vaccinia virus have been used for decades to protect against smallpox and provide cross-protection against mpox. Since the resurgence of mpox outbreaks globally, targeted vaccination campaigns have been deployed for high-risk groups.

Vaccination enhances immune memory beyond natural infection alone. It primes the immune system without causing disease symptoms but stimulates antibody production and T-cell responses similar to actual infection.

People vaccinated after recovering from mpox likely gain stronger protection against future infections. Conversely, unvaccinated individuals rely solely on natural immunity which might be less predictable in duration or strength.

Vaccines currently authorized for mpox prevention include:

JYNNEOS (Imvamune/Imvanex): A non-replicating vaccine approved for prevention of both smallpox and mpox.
ACAM2000: A live replicating vaccine used primarily for smallpox but with some off-label use for mpox.

Both vaccines reduce severity if breakthrough infections occur and lower transmission risk within communities.

Molecular Variants: Could They Undermine Immunity?

Viruses mutate over time; some changes can alter surface proteins targeted by antibodies. For SARS-CoV-2 (COVID-19), this phenomenon led to reinfections despite previous exposure or vaccination.

Mpox virus also has genetic clades—mainly West African and Congo Basin—with differing virulence profiles. Though mutation rates are slower compared to RNA viruses like influenza or coronaviruses, new variants could theoretically reduce immune recognition.

Continuous genomic surveillance monitors viral changes globally during outbreaks. So far, no major variant has completely escaped existing immunity induced by infection or vaccination.

Still, slight antigenic differences might explain occasional reinfections seen in clinical reports.

Treatment Implications If You Get Mpox Again

If someone contracts mpox a second time—whether due to waning immunity or exposure to a variant—the clinical course may differ from their first episode:

Milder Symptoms: Partial immunity often reduces illness severity.
Treatment Options: Antiviral drugs like tecovirimat (TPOXX) remain effective for managing symptoms.
Isolation Measures: Reinfections require standard precautions to prevent spread.

Healthcare providers should consider prior infection history when diagnosing new suspected cases but not rule out reinfection solely based on past illness.

Prompt antiviral treatment combined with supportive care shortens disease duration regardless of whether it’s a first-time or repeat infection.

Mild vs Severe Reinfections: What Does Data Show?

Available case reports suggest most reinfections tend toward mild disease courses—likely because immune memory blunts viral replication early on. However:

Immunocompromised individuals might experience more severe symptoms.
Delays in diagnosis or treatment could worsen outcomes.
Secondary bacterial infections remain a risk during skin lesions healing phase regardless of initial severity.

Therefore, vigilance remains crucial even if prior infection occurred months ago.

The Public Health Perspective on Mpox Reinfection Risks

From a population standpoint, understanding if “Can You Get Mpox More Than Once?” informs strategies including vaccination priorities and outbreak containment measures.

Key points include:

Disease Surveillance: Tracking confirmed reinfections helps assess community-level immunity gaps.
Vaccination Campaigns: Boosters may be recommended if evidence shows waning protection over time.
Epidemiological Modeling: Predicting outbreak dynamics requires factoring in possible repeat cases.
Risk Communication: Public messaging must clarify that prior infection doesn’t guarantee indefinite protection.

Such approaches reduce transmission chains by encouraging preventive behaviors even among those who recovered previously.

A Closer Look at Reinfection Statistics Worldwide

Although exact global numbers remain sparse due to limited testing capacity in many regions:

Most outbreaks report low percentages (<1%) of suspected reinfections.
Higher rates appear among immunocompromised patients.
Regions with widespread vaccination show fewer breakthrough cases overall.

Continued research will refine these estimates as new data emerges from surveillance networks coordinated by WHO and CDC affiliates worldwide.

Key Takeaways: Can You Get Mpox More Than Once?

➤ Reinfection is rare but possible.

➤ Immunity may not be lifelong.

➤ Protective measures remain important.

➤ Vaccination reduces risk significantly.

➤ Consult healthcare if symptoms recur.

Frequently Asked Questions

Yes, it is possible to get mpox more than once, although reinfections are rare. Immunity from the first infection usually protects against future infections, but it may not be lifelong or fully effective against different virus strains.

How Does Immunity Affect Whether You Can Get Mpox More Than Once?

Immunity after mpox infection involves antibodies and memory immune cells that help prevent reinfection. However, immune protection can weaken over time, making it possible to get mpox again, especially if exposed to a different variant or after several months or years.

What Factors Influence If You Can Get Mpox More Than Once?

Several factors affect reinfection risk, including immune system strength, virus variants, time since first infection, and the level of virus exposure. Individuals with weakened immunity or high-dose exposure may be more susceptible to getting mpox again.

Are Reinfections Common When You Can Get Mpox More Than Once?

Reinfections with mpox are considered rare. Most people develop a strong immune response that prevents repeated infections, but documented cases show that reinfection can occur, particularly in recent outbreaks involving new virus strains.

Does Getting Mpox More Than Once Mean the Second Infection Is More Severe?

Usually, if someone gets mpox more than once, the immune system helps reduce the severity of the second infection. While reinfection is possible, prior immunity often leads to milder symptoms or quicker recovery compared to the initial infection.

The Bottom Line – Can You Get Mpox More Than Once?

Yes—getting infected with mpox more than once is possible but uncommon. Natural infection usually triggers protective immunity lasting months or years; however:

This protection isn’t guaranteed lifelong nor absolute against all variants.
Certain individuals—especially those with weakened immune systems—face higher risks of reinfection.
The presence of different viral clades may influence susceptibility despite prior exposure.
Mild disease upon repeat infection is typical due to partial immune memory activation.

Vaccination remains a key tool for boosting defenses beyond natural infection alone. Maintaining awareness around personal risk factors helps guide timely medical care if symptoms recur after recovery from an earlier episode.

Understanding “Can You Get Mpox More Than Once?” empowers people with realistic expectations about their health status post-infection while supporting public health efforts aimed at controlling spread through vaccination and education campaigns alike.